Cite
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma.
MLA
Giri, Sabeena, et al. “Initial Insights into the Interaction of Antibodies Radiolabeled with Lutetium-177 and Actinium-225 with Tumor Microenvironment in Experimental Human and Canine Osteosarcoma.” Nuclear Medicine and Biology, vol. 134–135, July 2024, p. 108917. EBSCOhost, https://doi.org/10.1016/j.nucmedbio.2024.108917.
APA
Giri, S., Allen, K. J. H., Prabaharan, C. B., Ramirez, J. B., Fiore, L., Uppalapati, M., & Dadachova, E. (2024). Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma. Nuclear Medicine and Biology, 134–135, 108917. https://doi.org/10.1016/j.nucmedbio.2024.108917
Chicago
Giri, Sabeena, Kevin J H Allen, Chandra Bose Prabaharan, Jonathan Bonet Ramirez, Luciano Fiore, Maruti Uppalapati, and Ekaterina Dadachova. 2024. “Initial Insights into the Interaction of Antibodies Radiolabeled with Lutetium-177 and Actinium-225 with Tumor Microenvironment in Experimental Human and Canine Osteosarcoma.” Nuclear Medicine and Biology 134–135 (July): 108917. doi:10.1016/j.nucmedbio.2024.108917.